UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species

Antimicrobial agents and chemotherapy, 2019-12, Vol.64 (1)

2019

Volltextzugriff (PDF)

In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4608-4613

2012

Volltextzugriff (PDF)

Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents

PloS one, 2013-12, Vol.8 (12), p.e84409-e84409

2013

Volltextzugriff (PDF)

Monitoring Antibiotic Resistance in Ocular Microorganisms: Results From the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance Study

American journal of ophthalmology, 2011-10, Vol.152 (4), p.567-574.e3

2011

Volltextzugriff (PDF)

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Antimicrobial agents and chemotherapy, 2024-05, Vol.68 (5), p.e0158423

2024

Volltextzugriff (PDF)

Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution

Diagnostic microbiology and infectious disease, 2018-11, Vol.92 (3), p.250-252

2018

Volltextzugriff (PDF)

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3552-3560

2009

Volltextzugriff (PDF)

Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus

Diagnostic microbiology and infectious disease, 2017-02, Vol.87 (2), p.121-128

2017

Volltextzugriff (PDF)

In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp

Diagnostic microbiology and infectious disease, 2017-11, Vol.89 (3), p.205-211

2017

Volltextzugriff (PDF)

Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci

Journal of antimicrobial chemotherapy, 2017-02, Vol.72 (2), p.622-624

2017

Volltextzugriff (PDF)

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

PloS one, 2022-09, Vol.17 (9), p.e0274815-e0274815

2022

Volltextzugriff (PDF)

In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States

Antimicrobial Agents and Chemotherapy, 2008-12, Vol.52 (12), p.4388-4399

2008

Volltextzugriff (PDF)

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest

Journal of Clinical Microbiology, 2008-09, Vol.46 (9), p.2862-2867

2008

Volltextzugriff (PDF)

Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4762-4771

2009

Volltextzugriff (PDF)

Evaluation of the Bactericidal Activity of Telavancin Against Staphylococcus aureus using Revised Testing Guidelines

Diagnostic microbiology and infectious disease, 2017-09, Vol.89 (1), p.83-85

2017

Volltextzugriff (PDF)

Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae

Journal of antimicrobial chemotherapy, 2010-07, Vol.65 (7), p.1441-1447

2010

Volltextzugriff (PDF)

Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010

Diagnostic microbiology and infectious disease, 2012-07, Vol.73 (3), p.267-270

2012

Volltextzugriff (PDF)

In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters

Antimicrobial agents and chemotherapy, 2015-04, Vol.59 (4), p.2426-2427

2015

Volltextzugriff (PDF)

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

Antimicrobial Agents and Chemotherapy, 2008-07, Vol.52 (7), p.2383-2388

2008

Volltextzugriff (PDF)

In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.595-602

2008

Volltextzugriff (PDF)

In vitro time―kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 (4), p.840-844

2011

Volltextzugriff (PDF)

Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant Pathogens

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4911-4914

2014

Volltextzugriff (PDF)

Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs

Diagnostic microbiology and infectious disease, 2008-02, Vol.60 (2), p.221-224

2008

Volltextzugriff (PDF)

Correlation between oritavancin and vancomycin minimum inhibitory concentrations in staphylococci

International journal of antimicrobial agents, 2012-12, Vol.40 (6), p.562-563

2012

Volltextzugriff (PDF)

In Vitro Activities of Omadacycline and Comparators against Anaerobic Bacteria

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species

In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents

Monitoring Antibiotic Resistance in Ocular Microorganisms: Results From the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance Study

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus

In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp

Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest

Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates

Evaluation of the Bactericidal Activity of Telavancin Against Staphylococcus aureus using Revised Testing Guidelines

Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae

Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010

In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin

In vitro time―kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride

Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant Pathogens

Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs

Correlation between oritavancin and vancomycin minimum inhibitory concentrations in staphylococci

In Vitro Activities of Omadacycline and Comparators against Anaerobic Bacteria

Suchergebnisse filtern